CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Fluconazole

氟康唑 杂质对照品Fluconazole Impurities

EP31 个杂质条目31 impurity entries

本页汇总 氟康唑 的 31 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 31 impurity reference standards of Fluconazole with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 氟康唑(Fluconazole)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesMethod validation for the quantification of fluconazole and its organic impurities in raw material using high-performance liquid chromatography
    Biomedica : revista del Instituto Nacional de Salud · 2023 · Castillo JA, Afanasjeva N  ·  PMID 37721917  ·  DOI
  2. 杂质研究Impurity studiesPreparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS
    Journal of pharmaceutical and biomedical analysis · 2006 · Dongre VG et al.  ·  PMID 16757140  ·  DOI
  3. 杂质研究Impurity studiesIsolation and structural identification of an impurity in fluconazole bulk drug substance
    Journal of pharmaceutical and biomedical analysis · 2007 · Dongre VG et al.  ·  PMID 17706390  ·  DOI
  4. 分析方法Analytical MethodsValidation of an innovative analytical method for simultaneous quantification of curcumin and fluconazole using high-performance liquid chromatography from nanostructured lipid carriers
    Journal of separation science · 2021 · Araujo VHS et al.  ·  PMID 34598311  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisPediatric Coccidioidal Meningitis: A Systematic Review and Proportional Synthesis of Cases Reported in the Fluconazole Era (2000-2025)
    Journal of fungi (Basel, Switzerland) · 2025 · De la Cerda-Vargas MF et al.  ·  PMID 41149903  ·  DOI

氟康唑 —— 原料药与杂质对照品Fluconazole — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Fluconazole structure
EP原料药 APIAPI
氟康唑Fluconazole
Fluconazole
CAS No.86386-73-4
Chemical FormulaC13H12F2N6O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 1(Fluconazole EP Impurity A) structure
EPA
氟康唑杂质1(氟康唑EP杂质A)Fluconazole Impurity 1(Fluconazole EP Impurity A)
Fluconazole Impurity 1(Fluconazole EP Impurity A)
CAS No.89429-59-4
Chemical FormulaC13H12F2N6O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 2(Fluconazole EP Impurity B) structure
EPB
氟康唑杂质2(氟康唑EP杂质B)Fluconazole Impurity 2(Fluconazole EP Impurity B)
Fluconazole Impurity 2(Fluconazole EP Impurity B)
CAS No.871550-15-1
Chemical FormulaC15H14FN9O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 3(Fluconazole EP Impurity C) structure
EPC
氟康唑杂质3(氟康唑EP杂质C)Fluconazole Impurity 3(Fluconazole EP Impurity C)
Fluconazole Impurity 3(Fluconazole EP Impurity C)
CAS No.514222-44-7
Chemical FormulaC10H8N6
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 4(Fluconazole EP Impurity D) structure
EPD
氟康唑杂质4(氟康唑EP杂质D)Fluconazole Impurity 4(Fluconazole EP Impurity D)
Fluconazole Impurity 4(Fluconazole EP Impurity D)
CAS No.81886-51-3
Chemical FormulaC13H13FN6O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 5(Fluconazole EP Impurity E) structure
EPE
氟康唑杂质5(氟康唑EP杂质E)Fluconazole Impurity 5(Fluconazole EP Impurity E)
Fluconazole Impurity 5(Fluconazole EP Impurity E)
CAS No.86404-63-9
Chemical FormulaC10H7F2N3O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 6(Fluconazole EP Impurity F) structure
EPF
氟康唑杂质6(氟康唑EP杂质F)Fluconazole Impurity 6(Fluconazole EP Impurity F)
Fluconazole Impurity 6(Fluconazole EP Impurity F)
CAS No.118689-07-9
Chemical FormulaC11H11F2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 7 Monomer (Fluconazole EP Impurity G  Monomer) structure
EPG
氟康唑杂质7 单体 (氟康唑EP杂质G 单体)Fluconazole Impurity 7 Monomer (Fluconazole EP Impurity G Monomer)
Fluconazole Impurity 7 Monomer (Fluconazole EP Impurity G Monomer)
CAS No.86386-76-7
Chemical FormulaC11H9F2N3O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 7 (Fluconazole EP Impurity G) structure
EPG
氟康唑杂质7 (氟康唑EP杂质G)Fluconazole Impurity 7 (Fluconazole EP Impurity G)
Fluconazole Impurity 7 (Fluconazole EP Impurity G)
CAS No.86386-77-8
Chemical FormulaC11H9F2N3O·CH4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 8(Fluconazole EP Impurity H) structure
EPH
氟康唑杂质8(氟康唑EP杂质H)Fluconazole Impurity 8(Fluconazole EP Impurity H)
Fluconazole Impurity 8(Fluconazole EP Impurity H)
CAS No.150194-52-8
Chemical FormulaC11H10BrF2N3O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 9(Fluconazole EP Impurity I) structure
EPI
氟康唑杂质9(氟康唑EP杂质I)Fluconazole Impurity 9(Fluconazole EP Impurity I)
Fluconazole Impurity 9(Fluconazole EP Impurity I)
CAS No.150168-54-0
Chemical FormulaC13H14F2N7O+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 9 Monomer (Fluconazole EP Impurity I Monomer) structure
EPI
氟康唑杂质9单体(氟康唑EP杂质I单体)Fluconazole Impurity 9 Monomer (Fluconazole EP Impurity I Monomer)
Fluconazole Impurity 9 Monomer (Fluconazole EP Impurity I Monomer)
CAS No.749821-19-0
Chemical FormulaC13H14F2N7O+
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 11 structure
11
氟康唑杂质11Fluconazole Impurity 11
Fluconazole Impurity 11
CAS No.1348664-75-4
Chemical FormulaC13H13FN6O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 12 structure
12
氟康唑杂质12Fluconazole Impurity 12
Fluconazole Impurity 12
CAS No.98414-56-3
Chemical FormulaC7H8N6O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 14 structure
14
氟康唑杂质14Fluconazole Impurity 14
Fluconazole Impurity 14
CAS No.154534-83-5
Chemical FormulaC10H9F2N4O+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 16 structure
16
氟康唑杂质16Fluconazole Impurity 16
Fluconazole Impurity 16
CAS No.1997296-62-4
Chemical FormulaC13H12F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 17 structure
17
氟康唑杂质17Fluconazole Impurity 17
Fluconazole Impurity 17
CAS No.6086-21-1
Chemical FormulaC3H5N3
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 18 structure
18
氟康唑杂质18Fluconazole Impurity 18
Fluconazole Impurity 18
CAS No.5201-50-3
Chemical FormulaC3H6N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 19 structure
19
氟康唑杂质19Fluconazole Impurity 19
Fluconazole Impurity 19
CAS No.1774-47-6
Chemical FormulaC3H9IOS
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 20 structure
20
氟康唑杂质20Fluconazole Impurity 20
Fluconazole Impurity 20
CAS No.1222655-38-0
Chemical FormulaC14H14F2N6O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 2-d4 structure
2-D4
氟康唑杂质2-d4Fluconazole Impurity 2-d4
Fluconazole Impurity 2-d4
CAS No.1794817-03-0
Chemical FormulaC15H10D4FN9O
Purity>95%询价On request
Fluconazole Impurity 25 structure
25
氟康唑杂质25Fluconazole Impurity 25
Fluconazole Impurity 25
CAS No.584-13-4
Chemical FormulaC2H4N4
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 35 structure
35
氟康唑杂质35Fluconazole Impurity 35
Fluconazole Impurity 35
CAS No.173837-65-5
Chemical FormulaC9H10F2O3
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 39 (Simeconazole) structure
39
氟康唑杂质39 (硅氟唑)Fluconazole Impurity 39 (Simeconazole)
Fluconazole Impurity 39 (Simeconazole)
CAS No.149508-90-7
Chemical FormulaC14H20FN3OSi
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 40 structure
40
氟康唑杂质40Fluconazole Impurity 40
Fluconazole Impurity 40
CAS No.163921-62-8
Chemical FormulaC13H10F2N6
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 41 structure
41
氟康唑杂质41Fluconazole Impurity 41
Fluconazole Impurity 41
CAS No.163921-61-7
Chemical FormulaC13H10F2N6
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 42 structure
42
氟康唑杂质42Fluconazole Impurity 42
Fluconazole Impurity 42
CAS No.188416-33-3
Chemical FormulaC6H6BrClN2
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 43 structure
43
氟康唑杂质43Fluconazole Impurity 43
Fluconazole Impurity 43
CAS No.383127-79-5
Chemical FormulaC10H12BrN
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 44 structure
44
氟康唑杂质44Fluconazole Impurity 44
Fluconazole Impurity 44
CAS No.136134-23-1
Chemical FormulaC19H20F2N6O7
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 47 structure
47
氟康唑杂质47Fluconazole Impurity 47
Fluconazole Impurity 47
CAS No.876718-01-3
Chemical FormulaC10H9N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 48 structure
48
氟康唑杂质48Fluconazole Impurity 48
Fluconazole Impurity 48
CAS No.93739-75-4
Chemical FormulaC10H13N9O
Purity>95%询价On request
10mg25mg50mg100mg
Fluconazole Impurity 50 structure
50
氟康唑杂质50Fluconazole Impurity 50
Fluconazole Impurity 50
CAS No.70890-80-1
Chemical FormulaC2H2N4O2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

氟康唑 —— 研究文献与合成路线Fluconazole — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 氟康唑 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Fluconazole. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Time-of-flight mass spectrometry assessment of fluconazole and climbazole UV and UV/H2O2 degradability: Kinetics study and transformation products elucidation
    Castro G, Casado J, Rodríguez I, et al. · Water research · 2016 · 被引 24cited 24
  2. Photogeneration of hydroxyl radical in Fe(III)-citrate-oxalate system for the degradation of fluconazole: mechanism and products
    Wan D, Zhang G, Chen Y, et al. · Environmental science and pollution research international · 2019 · 被引 4cited 4
  3. Isolation and structural identification of an impurity in fluconazole bulk drug substance
    Dongre VG, Ghugare PD, Karmuse PP, et al. · Journal of pharmaceutical and biomedical analysis · 2007 · 被引 6cited 6
  4. Method validation for the quantification of fluconazole and its organic impurities in raw material using high-performance liquid chromatography
    Castillo JA, Afanasjeva N · Biomedica : revista del Instituto Nacional de Salud · 2023
  5. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS
    Dongre VG, Karmuse PP, Ghugre PD, et al. · Journal of pharmaceutical and biomedical analysis · 2006 · 被引 5cited 5
  6. Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations
    Abdel-Moety EM, Khattab FI, Kelani KM, et al. · Farmaco (Societa chimica italiana : 1989) · 2002 · 被引 32cited 32

合成与制备工艺专利Synthesis & process patents

  1. THIOPENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS FOR THEIR PREPARATION
    BORATE HANUMANT BAPURAO, SAWARGAVE SANGMESHWER PRABHAKAR, MAUJAN SULEMAN RUYAJSAHEB, CHANDAVARKAR MOHAN ANAND, et al. · 公开号 US2011144171US2011144171 · 2011
  2. Compound fluconazole ointment and preparation method thereof
    ZHIHUI HAO, RUILI ZHANG, YUANYUAN LIU, DEQIANG JIA · 公开号 CN101596204CN101596204 · 2009
  3. THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF
    BORATE HANUMANT BAPURAO, SAWARGAVE SANGMESHWER PRABHAKAR, MAUJAN SULEMAN RIYAJSAHEB, CHANDAVARKAR MOHAN ANAND, et al. · 公开号 EP2346861EP2346861 · 2011
  4. THIOPHENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS THEREOF
    BORATE HANUMANT BAPURAO, SAWARGAVE SANGMESHWER PRABHAKAR, MAUJAN SULEMAN RIYAJSAHEB, CHANDAVARKAR MOHAN ANAND, et al. · 公开号 WO2010046912WO2010046912 · 2010
  5. Process for preparing fluconazole intermediate 2,4-difluror bromo-benzene
    YE FAQING GUO · 公开号 CN1944361CN1944361 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

氟康唑 杂质谱研究要点Fluconazole — impurity profiling notes

下面这些是拿到 氟康唑 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Fluconazole, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances